心力衰竭治疗前后aVR导联QRS波振幅与脑钠肽的变化被引量：1

Analysis on changes of QRS-wave amplitude in aVR lead and brain natriuretic peptide before and after the treatment of heart failure

下载PDF

导出

摘要目的探讨心力衰竭患者利尿治疗前后aVR导联QRS波振幅与脑钠肽变化的关系,探讨心力衰竭治疗有效的心电图指标,为临床疗效评估提供简便易行的预测方法。方法观察心力衰竭患者50例,分别于入院时利尿治疗前及治疗后出院时行12导联心电图检查,观察aVR导联QRS波振幅变化;监测体重;测定脑钠肽浓度。结果心力衰竭患者经利尿治疗后心电图aVR导联QRS波的振幅较治疗前显著增高,体重显著下降,BNP显著下降。结论 aVR导联QRS波振幅变化与脑钠肽可以用来评估心力衰竭患者利尿治疗疗效的简单可靠的指标。 Objective To explore the changes of QRS-wave amplitude in aVR lead and brain natriuretic peptide（BNP） before and after the diuretic therapy for patients with heart failure, and to explore the effective indices of ECG for the treatment of heart failure, so as to provide easy predictions for the evaluation of clinical curative effects. Methods 50 patients with heart failure were observed and received 12-lead ECG before the diuretic therapy on admission and after the therapy on discharge. Changes of QRS-wave amplitude in aVR lead were observed; patients＇ weights were monitored; concentrations of BNP were tested. Results The QRS-wave amplitude in aVR lead for patients with heart failure after the diuretic therapy was significantly higher than that before the therapy. Patients＇ weights and BNP concentrations significantly reduced. Conclusion Changes of QRS-wave amplitude in aVR lead and BNP can be used as easy and reliable indices for the evaluation of curative effects of diuretic therapy for patients with heart failure.

作者荀平孙莉李恒斌尚怡君

机构地区吉林省吉林市中心医院心血管诊疗中心

出处《中国医药科学》 2014年第4期57-59,共3页 China Medicine And Pharmacy

关键词心力衰竭利尿剂 aVR导联QRS波振幅脑钠肽 Heart failure Diuretics QRS-wave amplitude in aVR lead Brain natriuretic peptide（BNP）

分类号 R540.41 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献11

1Ciccone MM, Cortese F, Gesualdo M, et al.A Novel Cardiac Bio-Marker:ST2:A review[J].Molecules, 2013,18 ( 12 ) : 15314-15328.
2Madias JE.Superiority of the limb leads over the precordial leads on the 12-lead ECG inmonitoring fluctuating fluid overload in a patient with congestive heart failure[J].J Electrocardiol, 2007,40: 395-399.
3Madias JE, Agarwal H, Win M, et al.Effect of weight loss in congestive heart failure from idiopathic dilated cardiomyopathy on electrocardiographic QRS voltage[J].Am J Cardiol, 2002,89 ( 1 ) : 86-88.
4Lumlertgul S, Chenthanakij B, Madias JE.ECG leads I and II to evaluate diuresis of patients with congestive heart failure admitted to the hospital via the emergency department[J]. Pacing Clin Electrophysiol, 2009,32 ( 1 ) : 64-71.
5Madias JE.aVR, an index of all ECG limb leads, with ctinical utility for monitoring of patients with edematous states, including heart failure[J].Pacing Clin Electrophysiol, 2009,32 ( 12 ) : 1567-1576.
6Madias JE, Song J, White CM, et al.Response of the ECG to short-term diuresis in patients with heart failure[J].Ann Noninvasive Electrocardiol, 2005,10 ( 3 ) : 288-296.
7John EM.On the Use of the Inverse Electrocardiogram Leads[J].Am J'Cardiol, 2009,103 ( 2 ) : 221-226.
8Madias JE, Attanti S, Narayan V.Relationship among electrocardiographic potential amplitude, weight, and resistance/reactance/impedance in a patient with peripheral edema treated for congestive heart failure[J].J Electrocardiol, 2003,36 ( 2 ) : 167-171.
9Madias JE.On the mechanism of augmentation of electrocardiogram QRS complexes in patients with congestive heart failure responding to diuresis[J].J Electrocardiol, 2005,38 ( 1 ) : 54-57.
10Cowie MR, Mendez GF.BNP and congestive heart failure[J].Prog Cardiovasc Dis, 2002,44 ( 4 ) : 293-321.